Our management board and team

Benedikt von Braunmühl

• Chairman of the Supervisory Board of Pathoquest
• Chiron Vaccines (predecessor to Novartis Vaccines & Diagnostics)
• Vice President Latin America & Member of the Americas Management Council at Qiagen
• Senior VP, Head of Global Commercial Operations and Member of the Executive Committee at Qiagen
• Chief Operating Officer Diagnostic Services at Medicover
• CEO of HMNC Brain Health in Munich, Germany
• Since September 2023, CEO at Rentschler Biopharma SE

See full Short CV

Christiane Bardroff

• Strong experience in the production of various biotechnology products, as well as in automation, IT and project management at Roche
• Senior Director Operations Biotech at Teva Biotech
• Since February 2022 SVP Client Program Management at Rentschler Biopharma
• Since May 2022 SVP Clinical and Commercial Manufacturing
• Since December 2022, Chief Operating Officer of Rentschler Biopharma SE

See full Short CV

Gunnar Voss van Dahlen

• Over 17 years of experience as a CFO in internationally active, mid-sized private and public companies
• Expertise in finance, controlling, law, IT, and human resource management
• International management positions in the US, UK, Singapore, and Switzerland
• Since December 2023, Financial Officer at Rentschler Biopharma SE 

See full Short CV

Tobias Glück

• Vice President Human Resources at Cameron
• Managing Director People & Organization at Novartis Germany GmbH
• Since October 2022, Global Head of Human Relations at Rentschler Biopharma and since February 2023, member of the Extended Executive Team

See full Short CV

Dr. Patrick Meyer

• PhD degree in molecular medicine and cellular biology
• Global Head BD Sales and Alliance Management at Rentschler Biopharma SE
• Since February 2025, Member of Executive Committee at Rentschler Biopharma SE
• Since February 2025, Global Head of Business Development at Rentschler Biopharma SE

Tom Roberts

• Leadership positions at Invictus Medical, 3M – KCI (formerly Acelity) and Roche Diagnostics
• Executive leadership, facilitated funding, and oversaw business and product development, regulatory compliance, manufacturing, and technology acquisition of a groundbreaking nanoparticle-based combination cancer therapeutic at Vitanova Biomedical
• Since September 2023, President Rentschler Biopharma Inc. and General Manager U.S., and member of the company’s Extended Executive Team

See full Short CV

Andreas Löwe

• Biological technical assistant in cGMP production at Fresenius
• Vice President Controlling and Member Management Executive Committee at Fresenius SE
• Vice President Controlling, Procurement and Projects at Neovii Biotech
• Since 2020 Vice President Finance at Rentschler Biopharma
• Since June 2023 part of the Extended Management Team

See full Short CV